Delivery Order SPE2DB22D1017-SPE2DB25FE9SQ

Award Date 11/21/24
Potential Completion Date 12/13/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,220.84, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3 ML) to support federal healthcare programs. The contract has an ultimate completion date of January 22, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
This is a $2,220.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes at 0.3 ML, with a completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,724.48, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes in 0.3 mL doses. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2024. The contract was awarded on November 13, 2024 and was not designated as a set-aside contract. AmerisourceBergen Drug...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML syringes. The $2,540.60 firm fixed-price contract has a completion date of June 16, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes 0.3 ML, with a ceiling value of $1,480.58. It is a firm fixed-price delivery order contract that does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed price delivery order is for COMIRNATY 2024-25 (12Y UP) syringes, 0.3ML, with a completion date of February 4, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,270.30, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML, with a performance period ending on April 29, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,220.84, is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes in 0.3 mL size. The contract has a completion date of January 6, 2025 and uses a firm fixed-price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $7,335.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of COMIRNATY 2024-25 (12 years and up) syringes, 0.3 mL, and is a firm fixed-price delivery order with a completion date of November 6, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML). The contract has a ceiling value of $1,480.58 and a period of performance through February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9SQ
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,220.84, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes 0.3mL. It is a firm fixed-price delivery order contract with a completion date of December 13, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 1:45 PM